Cutting Edge: NKp80 Uses an Atypical Hemi-ITAM To Trigger NK Cytotoxicity

被引:37
作者
Dennehy, Kevin M. [2 ,3 ]
Klimosch, Sascha N. [1 ]
Steinle, Alexander [1 ,2 ]
机构
[1] Goethe Univ Frankfurt, Inst Mol Med, D-60590 Frankfurt, Germany
[2] Univ Tubingen, Dept Immunol, D-72076 Tubingen, Germany
[3] Univ Tubingen, Inst Med Virol, D-72076 Tubingen, Germany
关键词
NATURAL-KILLER-CELLS; ACTIVATION; KINASE; SYK; CLEC-2; SUBSET; SIGNAL;
D O I
10.4049/jimmunol.0904117
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The human NK cell receptor NKp80 stimulates cytotoxicity upon engagement of its genetically linked ligand AICL. However, the mechanisms underlying NKp80-mediated signaling are unknown. In this study, we dissected NKp80 signaling using the NK cell line NK92MI. We demonstrated that NKp80, but not NKp80 mutated at tyrosine 7 (NKp80/Y7F), is tyrosine phosphorylated. Accordingly, NKp80/Y7F, but not NKp80/Y30F or NKp80/Y37F, failed to induce cytotoxicity. NKp80 phosphopeptides comprising the hemi-ITAM-like sequence surrounding tyrosine 7 bound Lck- and Syk-family kinases; accordingly, cross-linking of NKp80, but not NKp80/Y7F, induced Syk phosphorylation. Moreover, inhibition of Syk kinase, but not ZAP-70 kinase, impaired cytotoxic responses through NKp80. Atypical residues in the hemi-ITAM-like motif of NKp80 cause an altered stoichiometry of phosphorylation but did not substantially affect NK cytotoxicity. Altogether, these results show that NKp80 uses an atypical hemi-ITAM and Syk kinase to trigger cellular cytotoxicity. The Journal of Immunology, 2011, 186: 657-661.
引用
收藏
页码:657 / 661
页数:5
相关论文
共 19 条
[1]   R406, an orally available spleen tyrosine kinase inhibitor blocks Fc receptor signaling and reduces immune complex-mediated inflammation [J].
Braselmann, Sylvia ;
Taylor, Vanessa ;
Zhao, Haoran ;
Wang, Su ;
Sylvain, Catherine ;
Baluom, Muhammad ;
Qu, Kunbin ;
Herlaar, Ellen ;
Lau, Angela ;
Young, Chi ;
Wong, Brian R. ;
Lovell, Scott ;
Sun, Thomas ;
Park, Gary ;
Argade, Ankush ;
Jurcevic, Stipo ;
Pine, Polly ;
Singh, Rajinder ;
Grossbard, Elliott B. ;
Payan, Donald G. ;
Masuda, Esteban S. .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2006, 319 (03) :998-1008
[2]   Mitogenic CD28 signals require the exchange factor Vav1 to enhance TCR signaling at the SLP-76-Vav-Itk signalosome [J].
Dennehy, Kevin M. ;
Elias, Fernando ;
Na, Shin-Young ;
Fischer, Klaus-Dieter ;
Huenig, Thomas ;
Luehder, Fred .
JOURNAL OF IMMUNOLOGY, 2007, 178 (03) :1363-1371
[3]   The C-type lectin receptors CLEC-2 and Dectin-1, but not DC-SIGN, signal via a novel YXXL-dependent signaling cascade [J].
Fuller, Gemma L. J. ;
Williams, Jennifer A. E. ;
Tomlinson, Michael G. ;
Eble, Johannes A. ;
Hanna, Sheri L. ;
Pohlmann, Stefan ;
Suzuki-Inoue, Katsue ;
Ozaki, Yukio ;
Watson, Steve P. ;
Pearce, Andrew C. .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2007, 282 (17) :12397-12409
[4]   CLEC9A is a novel activation C-type lectin-like receptor expressed on BDCA3+ dendritic cells and a subset of monocytes [J].
Huysamen, Cristal ;
Willment, Janet A. ;
Dennehy, Kevin M. ;
Brown, Gordon D. .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2008, 283 (24) :16693-16701
[5]   Pivotal role of phosphoinositide-3 kinase in regulation of cytotoxicity in natural killer cells [J].
Jiang, K ;
Zhong, B ;
Gilvary, DL ;
Corliss, BC ;
Hong-Geller, E ;
Wei, S ;
Djeu, JY .
NATURE IMMUNOLOGY, 2000, 1 (05) :419-425
[6]  
Kitamura T, 1998, INT J HEMATOL, V67, P351
[7]  
Kuttruff S, 2009, BLOOD, V113, P358, DOI [10.1182/blood-2008-04-145615, 10.1182/blood-2008-03-145615]
[8]   Up on the tightrope: natural killer cell activation and inhibition [J].
Lanier, Lewis L. .
NATURE IMMUNOLOGY, 2008, 9 (05) :495-502
[9]  
MacFarlane AW, 2006, CURR TOP MICROBIOL, V298, P23
[10]   Myeloid C-type lectins in innate immunity [J].
Robinson, Matthew J. ;
Sancho, David ;
Slack, Emma C. ;
LeibundGut-Landmann, Salome ;
Sousa, Caetano Reis e .
NATURE IMMUNOLOGY, 2006, 7 (12) :1258-1265